Healthcare

The majority of the country’s pharma manufacturing produces generic drugs.

This is expected to affect local pharma growth in the short term.

The launch of dual chamber leadless pacemakers can especially promote market growth.

The region held the second-largest revenue share for the market in 2020.

Nonetheless, more than half of the age group found its use to be comfortable.

The group’s profits after tax ballooned by as much as 138.4%.

The growing presence of the private healthcare sector is promoting growth.

Supportive government initiatives are expected to propel market growth.

Funds will be used to build out its behavioural health and chronic care modules.

Over 22,000 healthcare providers are now issuing e-prescriptions.

Some players have been highly active in digital channels of various countries.

It has also formed a JV with Acurio to develop a private hospital in NSW.

Flexible video gastroscopes accounted for over 90% of the market.

The device is mainly used for patients with intracranial atherosclerotic disease (ICAD).

With this, the company now offers an all-in-one patient management service.

The therapy can be done in eight different languages.